This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next
Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update. The results were not to the market's liking, so much so that they led to a significant post-earnings dip for the stock. Shares are still in the green year to date, but only barely.However, Vertex's past stock-market meltdowns -- and what happened afterward -- might suggest that its most recent drop represents an excellent buying opportunity.Image source: Getty Images.Continue reading
Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update. The results were not to the market's liking, so much so that they led to a significant post-earnings dip for the stock. Shares are still in the green year to date, but only barely.
However, Vertex's past stock-market meltdowns -- and what happened afterward -- might suggest that its most recent drop represents an excellent buying opportunity.
Image source: Getty Images.
